Semaglutide GLP-1 works as a GLP-1 receptor agonist to regulate appetite and blood sugar, while tirzepatide combines GIP and GLP-1 receptor agonist actions for enhanced weight loss benefits
Consoli A, Formoso G, Baldassarre MPA, Febo F
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences
If tolerated, acarbose can be increased to 50 to 100 mg with 3 meals daily
They do show that weight maintenance should be discussed early, before a patient reaches a goal weight or stops treatment abruptly
For NYC patients approaching Medicare or already enrolled in Part D, this may become an important bridge between todays uneven obesity-drug coverage and broader future access